ICON plc dans l'actualité
Conseil et services en développement de médicaments
Tamtam a trouvé 20 articles récents sur ICON plc.
- ICON PLC (ICLR) Is Leveraging AI to Accelerate Clinical Trials
- U.S. Markets Rose Wednesday; Icon PLC Topped Leaders
- Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates
- Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
- Icon (ICLR) Stock Forecast and Price Target 2026 $ICLR
- BofA Securities Upgrades Icon PLC (ICLR) to Neutral, Lifts Price Target Amid Positive CRO Outlook
- ICON plc Stock 12‑Month Price Target Raised to $187.81, Implies 14% Upside
- Results arrive after market close October 27 for ICON (ICLR), with an earnings call October 28.
- Is Icon PLC (ICLR) a Bargain After 3.9% Drop? GF Value Says Unde
- ICON plc (ICLR) rises as investors appear to lean on backlog, guidance, and recent filings
- S&P 500 Futures Rise in Premarket Trading; Xenon Pharmaceuticals, Icon PLC Lag
- White & Case advises ICON on its US$2.15 billion notes offering and related secured debt refinancing
- Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
- ICON plc (ICLR) Surged 57% in Q2 After Accounting Clarity
- Icon PLC (ICLR) Lags Q2 Earnings Estimates
- Icon PLC (ICLR) Up 5.8% Since Last Earnings Report: Can It Continue?
- Icon defends claim it left investors with ‘billions in losses’
- Earnings Preview: Icon PLC (ICLR) Q2 Earnings Expected to Decline
- ICON plc Selects Microsoft (MSFT) As Preferred Technology Partner
- Greenskeeper Asset Management Increased Its Holdings in ICON Plc (ICLR) Amid Market Fear
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme ICON plc ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires